BlackRock Investment Management, LLC - ELEVEN BIOTHERAPEUTICS INC ownership

ELEVEN BIOTHERAPEUTICS INC's ticker is EBIO and the CUSIP is 286221106. A total of 41 filers reported holding ELEVEN BIOTHERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of ELEVEN BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2016$1,000
-80.0%
1,7930.0%0.00%
Q4 2015$5,000
+25.0%
1,7930.0%0.00%
Q3 2015$4,000
-20.0%
1,7930.0%0.00%
Q2 2015$5,000
-96.1%
1,793
-87.5%
0.00%
Q1 2015$128,000
-17.4%
14,382
+10.1%
0.00%
Q4 2014$155,000
+5.4%
13,068
-0.7%
0.00%
Q3 2014$147,000
-16.9%
13,155
-2.2%
0.00%
Q2 2014$177,000
+13.5%
13,451
+39.8%
0.00%
Q1 2014$156,0009,6200.00%
Other shareholders
ELEVEN BIOTHERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,907,008$21,244,00014.99%
Third Rock Ventures, LLC 4,841,591$53,935,0006.29%
Broadfin Capital, LLC 857,715$9,555,0001.00%
NJ State Employees Deferred Compensation Plan 25,000$278,0000.06%
SECTORAL ASSET MANAGEMENT INC 112,485$1,253,0000.05%
C WorldWide Group Holding A/S 100,000$1,161,0000.02%
Tower Research Capital LLC (TRC) 9,921$111,0000.01%
SABBY MANAGEMENT, LLC 19,997$223,0000.01%
Ground Swell Capital, LLC 402$4,0000.01%
Point72 Asset Management, L.P. 55,450$618,0000.01%
View complete list of ELEVEN BIOTHERAPEUTICS INC shareholders